ES2045141T3 - Composicion de materia para incrementar los niveles intracelulares de atp y los niveles de rendimiento fisico y para incrementar la cadencia de reparacion de las heridas. - Google Patents

Composicion de materia para incrementar los niveles intracelulares de atp y los niveles de rendimiento fisico y para incrementar la cadencia de reparacion de las heridas.

Info

Publication number
ES2045141T3
ES2045141T3 ES88309826T ES88309826T ES2045141T3 ES 2045141 T3 ES2045141 T3 ES 2045141T3 ES 88309826 T ES88309826 T ES 88309826T ES 88309826 T ES88309826 T ES 88309826T ES 2045141 T3 ES2045141 T3 ES 2045141T3
Authority
ES
Spain
Prior art keywords
levels
increase
atp
wound repair
physical performance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88309826T
Other languages
English (en)
Inventor
Francis J Carniglia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2045141T3 publication Critical patent/ES2045141T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)

Abstract

UNA COMPOSICION DE MATERIA PARA INCREMENTAR LA SINTESIS INTRACELULAR DE ATP. LA COMPOSICION CONSTA DE AMINOACIDOS, METABOLITOS, ELECTROLITOS Y UN AZUCAR PENTOSA. CUANDO SE APLICA A HERIDAS, EL INVENTO INCREMENTA EL INDICE DE SEPARACION DE LA HERIDA. CUANDO SE ADMINISTRA ORALMENTE, EL INVENTO INCREMENTA LOS NIVELES DE ATP EN SANGRE Y LOS NIVELES DE REPRESENTACION FISICA.
ES88309826T 1987-12-29 1988-10-19 Composicion de materia para incrementar los niveles intracelulares de atp y los niveles de rendimiento fisico y para incrementar la cadencia de reparacion de las heridas. Expired - Lifetime ES2045141T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/139,288 US4871718A (en) 1987-12-29 1987-12-29 Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair

Publications (1)

Publication Number Publication Date
ES2045141T3 true ES2045141T3 (es) 1994-01-16

Family

ID=22485942

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88309826T Expired - Lifetime ES2045141T3 (es) 1987-12-29 1988-10-19 Composicion de materia para incrementar los niveles intracelulares de atp y los niveles de rendimiento fisico y para incrementar la cadencia de reparacion de las heridas.

Country Status (12)

Country Link
US (2) US4871718A (es)
EP (1) EP0324227B1 (es)
JP (1) JPH01175939A (es)
AT (1) ATE77557T1 (es)
AU (1) AU600139B2 (es)
CA (1) CA1325593C (es)
DE (2) DE3872372T2 (es)
DK (1) DK726088A (es)
ES (1) ES2045141T3 (es)
GR (1) GR900300016T1 (es)
IE (1) IE62263B1 (es)
NZ (1) NZ225106A (es)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
IT1247125B (it) * 1991-03-01 1994-12-12 Depha Team Srl Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco.
US5195940A (en) * 1991-06-20 1993-03-23 Iatromed, Inc. Method for increased production of growth factor in living tissue using an applied fluctuating magnetic field
CA2078019C (en) * 1991-09-13 2002-08-27 Siegbert Heinrich Bissbort Substance or composition and uses thereof
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
EP1719510A1 (en) * 1994-11-08 2006-11-08 Avicenda Group, Inc. Use of creatine or creatine analogs for the tratment of diseases of the nervous system
WO1996022019A1 (en) * 1995-01-20 1996-07-25 Carniglia Francis J Diet compositions to treat ascites in domestic animals
WO1996033703A2 (en) * 1995-04-25 1996-10-31 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US5827874A (en) * 1995-05-05 1998-10-27 Meyer; Hans Methods of treating pain and inflammation with proline
US5571518A (en) 1995-10-30 1996-11-05 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing tricholine citrate
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US7150880B2 (en) * 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US8128955B2 (en) * 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6218366B1 (en) * 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
GB9814039D0 (en) * 1998-06-29 1998-08-26 Univ London Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury
FR2782270B1 (fr) * 1998-08-12 2001-06-22 Michel Seman Adenosine et nucleotides adenyliques par voie orale pour l'amelioration du travail musculaire
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US20020119933A1 (en) * 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
AU7828200A (en) 1999-09-23 2001-04-24 Juvenon Corporation Nutritional supplement for increased energy and stamina
US6339716B1 (en) 1999-09-24 2002-01-15 Bioenergy Inc. Method for determining viability of a myocardial segment
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
EP1248609A4 (en) 1999-11-03 2007-08-01 Juvenon Inc METHOD FOR TREATING THE GOOD MEMORY TROUBLESHOOTING
EP1282424A1 (en) 2000-01-07 2003-02-12 Bioenergy Inc. compositions for enhancing the immune response
KR100338491B1 (ko) * 2000-03-30 2002-05-30 채수경 인중합체로 된 흉터 억제 및 상처 회복 촉진제
US7713546B1 (en) 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US6553254B1 (en) * 2000-04-07 2003-04-22 Keith E. Kenyon Combination of non-living-source physical energy and living-source chemical energy to maximize the salvage of ATP
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
DE60125191T2 (de) * 2000-07-28 2007-10-25 Bioenergy Inc., Ham Lake Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion
JP2002338473A (ja) * 2001-05-15 2002-11-27 Yaizu Suisankagaku Industry Co Ltd 抗疲労組成物
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030069203A1 (en) * 2001-06-04 2003-04-10 Lee Steve S. Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
US20040147458A1 (en) * 2002-03-28 2004-07-29 Van Tassel Richard K Compositions to reduce exercise-induced swelling of joints
US20040127428A1 (en) * 2002-12-28 2004-07-01 Kenyon Keith E. Use of D-ribose, including as a topical vehicle, to promote faster healing, including from surgical procedures
US7494643B2 (en) * 2003-07-22 2009-02-24 Rendon Marta I Method and topical composition for the treatment of hyperpigmented skin
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US8105583B2 (en) * 2003-09-29 2012-01-31 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
AU2005216192B2 (en) * 2004-02-23 2010-11-04 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
WO2005089774A1 (en) * 2004-03-18 2005-09-29 Tanabe Seiyaku Co., Ltd. D-ribose for improving depression-like symptoms
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
EP1737429B1 (en) 2004-04-19 2013-07-17 Strategic Science & Technologies, LLC Transdermal delivery of beneficial substances effected by a high ionic strength environment
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2005336176A (ja) * 2004-04-28 2005-12-08 Tanabe Seiyaku Co Ltd 肉体疲労改善剤
AU2005308538A1 (en) * 2004-08-09 2006-06-01 Enrique Melendez Hevia Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
US20050249803A1 (en) * 2005-06-03 2005-11-10 Udell Ronald G Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
WO2007029730A1 (ja) * 2005-09-06 2007-03-15 Meiji Dairies Corporation 老人性貧血を防止又は治療するためのアミノ酸組成物
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss
US7989009B2 (en) * 2006-02-02 2011-08-02 Advocare International, L.P. Composition and method for promoting weight loss
US7745487B2 (en) * 2006-07-17 2010-06-29 Quercegen Pharma Llc Method for enhancing physical performance or immune system recovery from intense physical excercise with quercetin-containing compositions
WO2008011363A2 (en) * 2006-07-17 2008-01-24 Thomas Christian Lines Quercetin-containing compositions
US7615324B2 (en) * 2007-03-14 2009-11-10 Fujifilm Corporation Photosensitive composition, and cured relief pattern production method and semiconductor device using the same
US20080226696A1 (en) * 2007-03-15 2008-09-18 Ben Treadwell Methods of improving learning abilities of aged companion animals
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
US20090061016A1 (en) * 2007-09-05 2009-03-05 Selzer Jonathan A Seawater Based Dietary Supplement Product for Energy and Electrolyte Replacement
JP5235439B2 (ja) * 2008-02-06 2013-07-10 丸善製薬株式会社 ＨＭＧ−ＣｏＡ還元酵素産生促進剤
US20090005320A1 (en) * 2008-09-02 2009-01-01 Bruce Kneller Compositions comprising amino acid bicarbonate and methods of use thereof
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2445493A1 (en) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN102481275B (zh) 2009-06-24 2014-07-23 战略科学技术有限公司 含有布洛芬的表面组合物
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
JP5823985B2 (ja) * 2010-02-16 2015-11-25 ビアセル，リミティド ライアビリティ カンパニー 赤血球を治療するためのアルギニン含有組成物および方法
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
US11730760B2 (en) 2011-04-01 2023-08-22 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
US11389663B2 (en) 2011-04-01 2022-07-19 Bioregentech, Inc. Laser assisted wound healing protocol and system
EP2859889A1 (en) * 2013-10-14 2015-04-15 Abbott Laboratories Compositions and methods for improving cognitive function
EP4241838A3 (en) 2016-02-01 2023-12-20 Bioenergy Life Science, Inc. Use of ribose for treatment of subjects having congestive heart failure
US11654293B2 (en) * 2016-11-10 2023-05-23 The Bioregentech Institute, Inc. Laser assisted wound healing protocol and system
WO2018089954A1 (en) 2016-11-10 2018-05-17 BioRegentech Laser assisted wound healing protocol and system
CN111655072A (zh) * 2018-01-25 2020-09-11 吴世仁 具有不同长度的牙刷毛的牙刷
WO2020112828A1 (en) 2018-11-30 2020-06-04 Zwicker Jeffrey I Compositions and methods for reducing major thrombotic events in cancer patients
WO2023135827A1 (ja) * 2022-01-13 2023-07-20 ＮｅＳＡ合同会社 神経変性疾患の進行遅延及び防御剤

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2417841A (en) * 1944-06-21 1947-03-25 Frances R Ruskin Nucleotide compounds of components of vitamin b complex
US2844514A (en) * 1953-11-04 1958-07-22 Pabst Brewing Co Process for the production of nucleotides
US3009859A (en) * 1958-07-22 1961-11-21 Laborit Henri Potassium aspartate and magnesium aspartate fatigue-recovery promoting process and compositions
US3104203A (en) * 1959-12-09 1963-09-17 Union Carbide Corp Composition of matter containing procaine adenylate
US3157635A (en) * 1960-08-05 1964-11-17 Takeda Chemical Industries Ltd Sulfonic acid cation exchange resin purification of nucleotides
DE1442304A1 (de) * 1962-08-08 1970-01-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Purinderivaten
US3329567A (en) * 1963-09-16 1967-07-04 Union Carbide Corp Synergistic effect of adenylic nucleotides in digitalis therapy
DE1692496A1 (de) * 1965-01-27 1971-08-05 Takeda Chemical Industries Ltd Futtermittel
US3931402A (en) * 1970-12-02 1976-01-06 Societa Prodotti Antibiotici S.P.A. Preparations containing hexoses
FR2129833B1 (es) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
US3819830A (en) * 1971-07-01 1974-06-25 Dainippon Pharmaceutical Co Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
US3978213A (en) * 1972-07-10 1976-08-31 Nelson Research & Development Company Cosmetic use of cyclic amp and phosphodiesterase inhibitors
ZA7465B (en) * 1973-01-16 1974-11-27 J Voorhees Proliferating skin diseases with acyl derivatives of cyclic adenosine monophosphate
US4211770A (en) * 1973-01-16 1980-07-08 The Upjohn Company Treatment of psoriasis intralesionally with N6 -2'-O-dibutyryl cyclic AMP
US3988466A (en) * 1973-06-01 1976-10-26 Kyowa Hakko Kogyo Co., Ltd. Prevention of gastric lesions
DE2509531A1 (de) * 1975-03-05 1976-09-16 Thomae Gmbh Dr K Antivirales mittel
US4363818A (en) * 1975-06-04 1982-12-14 Gottlieb Sheldon K Method for relief of burning, itching, and pain of cutaneous and mucosal surfaces
US4126701A (en) * 1975-10-24 1978-11-21 A.H.P., Inc. Process of sparing poultry from the effect of toxins
US4078971A (en) * 1976-03-31 1978-03-14 Temple University Bound, active cellular organelles and method of producing same
US4207315A (en) * 1976-10-20 1980-06-10 University Patents, Inc. Process for treating proliferative skin diseases using certain diamino compounds
US4414202A (en) * 1980-02-19 1983-11-08 Silvetti Anthony N Composition for treatment of wounds
US4308257A (en) * 1980-06-03 1981-12-29 Saul Caspe Accelerating cellular repair composition for the human body and method of administering same
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4546095A (en) * 1980-07-21 1985-10-08 Markov Angel K Use of fructose-1,6-diphosphate for treating myocardial infarction
FR2489145A1 (fr) * 1980-09-04 1982-03-05 Geistlich Soehne Ag Compositions pharmaceutiques accelerant la guerison de blessures
US4362745A (en) * 1980-11-19 1982-12-07 Johnston Frederick B Medical process and preparation
JPS58500526A (ja) * 1981-04-17 1983-04-07 アメリカン　ホスピタル　サプライ　コ−ポレ−シヨン 非経口栄養供給のための改良溶液
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
JPS58129970A (ja) * 1982-01-26 1983-08-03 Kazutomo Imahori アデノシン三リン酸変換用装置
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
DE3578124D1 (de) * 1984-01-18 1990-07-19 Oehmke Martin Niedrig osmotisches hypokalorisches waessriges praeparat fuer die infusion.
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4764375A (en) * 1985-09-11 1988-08-16 Kv Pharmaceutical Company Sachet drug delivery system
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
EP0226332B1 (en) * 1985-11-18 1992-03-25 Beecham Group Plc Veterinary compositions
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4923851A (en) * 1987-12-29 1990-05-08 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4945087A (en) * 1988-03-31 1990-07-31 Warner-Lambert Company Taste masking of thymol
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4983394A (en) * 1990-05-03 1991-01-08 Warner-Lambert Company Flavor enhancing and medicinal taste masking agent

Also Published As

Publication number Publication date
CA1325593C (en) 1993-12-28
JPH0520414B2 (es) 1993-03-19
GR900300016T1 (en) 1991-06-07
DE3872372T2 (de) 1992-12-10
IE882583L (en) 1989-06-29
NZ225106A (en) 1990-10-26
US4871718A (en) 1989-10-03
IE62263B1 (en) 1995-01-11
AU1769088A (en) 1989-06-29
US5391550A (en) 1995-02-21
EP0324227A1 (en) 1989-07-19
EP0324227B1 (en) 1992-06-24
DK726088A (da) 1989-06-30
DE324227T1 (de) 1989-11-16
ATE77557T1 (de) 1992-07-15
JPH01175939A (ja) 1989-07-12
AU600139B2 (en) 1990-08-02
DK726088D0 (da) 1988-12-28
DE3872372D1 (de) 1992-07-30

Similar Documents

Publication Publication Date Title
ES2045141T3 (es) Composicion de materia para incrementar los niveles intracelulares de atp y los niveles de rendimiento fisico y para incrementar la cadencia de reparacion de las heridas.
MX6223E (es) Procedimiento mejorado para la preparacion de provectiles balisticos que contienen una composicion biologicamente activa
IT1062219B (it) Glucopiranosido..i..6..mannite..procedimento per la sua preparazione e l'impiego della stessa come surrogato dello zucchero
MX162625A (es) Procedimiento para la preparacion de una pelicula de celulosa y pelicula de celulosa obtenida por el mismo
ES492400A0 (es) Procedimiento para la preparacion de derivados de (ergo- lin-il)-n',n'-dietilurea
AR221682A1 (es) Procedimiento para la preparacion de derivados de 2(imidazol-4-il,piridil-2-ilo o tiazolil-2-ilo-butil o metiltio-etilamino)-5-(1-naftil-alquilenoxi;1,3-benzodioxolil-alquilenoxi;1,4-benzodioxinilalquilenoxi;1-naftilalquilen;1,3-benzodioxolilalquilen;o 1,4-benzo dioxinilalquilen)-4-pirimidona o 4-pirimidintiona
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
ES516198A0 (es) "un procedimiento para la preparacion de derivados tetrassubstitudos del benceno".
ES2032628T3 (es) Metodo para producir una preparacion farmaceutica solida.
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
DE68900152D1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
MX8958A (es) Procedimiento para obtener un preparado liofilizado que contiene ifosfamida.
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
NO883986D0 (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
IT1208046B (it) Derivati 3-(idrossimetil)isochinolinici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
MX6962E (es) Procedimiento para la preparacion de una composicion farmaceutica antidiarreica
ES454501A1 (es) Un procedimiento para la preparacion de acidos pirrolidon- carboxilicos sustituidos en n.
IT8322401A0 (it) Procedimento per la preparazione della 5-(e)-(2-bromovinil)-2'--desossiuri dina e dei suoi derivati, ederivati della 5-(e)-(2--bromovinil)-2'-desossiuri dina.
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
IT214492Z2 (it) Scarpa con suola zavorrabile per uso sportivo o terapeutico.
ES534980A0 (es) Mejoras en el objeto de la patente principal n 528.903, por: mejoras introducidas en los mecanismos para movimiento de extremidades en los munecos
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
IT8547865A0 (it) Nuovi derivati della i,4-diidropiri dina,procedimento per la loro preparazione,e loro impiego come farmaci
IT8847578A0 (it) Derivati della pilocarpina, loro preparazione e loro impiego come medicamenti
MX146811A (es) Procedimiento para la preparacion de compuestos de 3-o 4-amino-3'o 4'-(beta-sulfatoetilsulfonilo)benzanilida

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 324227

Country of ref document: ES